Senti Biosciences share price logo

Senti Biosciences

NASDAQ: SNTI

$0.18

-0.01

(-5.37%)

as on

Senti Biosciences Stock Performance

as on November 4, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.17
    $0.19
    downward going graph

    4.44%

    Downside

    6.80%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.15
    $2.88
    downward going graph

    14.84%

    Downside

    1518.89%

    Upside

    downward going graph

Senti Biosciences share price movements today

Previous Close
$0.19
Open
$0.18
Volume
696.8K
Market Cap
$6.3M
Day's Low - High
$0.17 - $0.19
52 Week Low - High
$0.15 - $2.88

Senti Biosciences Historical Returns

1 Month Return
-41.67 %
3 Month Return
-49.2 %
1 Year Return
-90.6 %
3 Year Return
-93.65 %
5 Year Return
0 %

Senti Biosciences Stock Fundamentals & Key Indicators

Check Senti Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.3M

EPS (TTM)

-1.77

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.09

Industry PE ratio

-3.13

PEG Ratio

-0.00

EBITDA

-47.0M

Revenue (TTM)

55.0K

Profit Margin

-2736.36%

Return On Equity TTM

-1539.97%

Senti Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Senti Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Senti Biosciences image
Senti Biosciences
Buy$6.3MNA-0.09-2736.36%0.00%
Moderna image
Moderna
Neutral$88.5B-36.16%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B192.56%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B47.41%19.7685.77%0.40%

Stock Returns calculator for Senti Biosciences Stock including INR - Dollar returns

The Senti Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Senti Biosciences investment value today

Current value as on today

₹9,498

Returns

-₹90,502

(-90.5%)

Returns from Senti Biosciences Stock

-₹91,105 (-91.1%)

Dollar Impact

₹603 (+0.60%)

Analyst Recommendation on Senti Biosciences Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Senti Biosciences. Average target price of $13.5

Senti Biosciences Share Price Target

Get share price movements and forecasts by analysts on Senti Biosciences.

What analysts predicted

98.68%UPSIDE

Target Price

$13.5

Current Price

$0.1779

Analyzed by

7 Analysts

Target

$13.50

Senti Biosciences target price $13.5, a slight upside of 98.68% compared to current price of $0.1779. According to 7 analysts rating.

Indian Investors' Interest in Senti Biosciences Stock

Search interest for Senti Biosciences Stock has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:32% versus previous 30 day period

Senti Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
0
0
0
Gross Profit
-1
-1
-
-1
-
-1
-
0
0
0
Operating Income
-16
-13
-15
-16
-16
-16
-16
-13
-11
-14
EBITDA
-10
-9
-13
0
-15
-13
-16
-13
-3
-13
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
0
1
0
0
0
0
Income Before Tax
-12
-11
-28
0
-14
-14
-18
-14
-4
-12
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-12
-11
-28
0
-14
-14
-18
-14
-4
-12
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-3959.09%
100.00%
-3823.53%

Senti Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
2
3
1
-
0
Gross Profit
-14
0
2
3
1
-
-3
Operating Income
-21
-24
-40
-62
-92
-61
-63
EBITDA
-20
-22
-52
-45
-61
-54
-57
Interest Expense
-
-
-
-
-
-
-
Depreciation
1
1
3
3
5
5
3
Income Before Tax
-21
-19
-55
-49
-83
-52
-61
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-21
-19
-55
-58
-71
-52
-61
Net Profit Margin
-16987.06%
100.00%
100.00%
100.00%
100.00%
0.00%
-16431.82%

Senti Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-12
-11
-28
0
-14
-14
-18
-14
-4
-12
Operating Cash Flow
-11
-8
-7
-13
-14
-13
-9
-6
-7
-14
Investing Cash Flow
0
-
0
0
-
0
-
0
0
-
Financing Cash Flow
-
-
2
51
0
1
0
11
0
9
Change in Cash
-11
-8
-5
37
-14
-12
-9
4
-7
-4

Senti Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-21
-19
-55
-58
-71
-52
-61
Operating Cash Flow
-18
-24
-34
-34
-52
-41
-43
Investing Cash Flow
3
11
-5
-81
30
0
0
Financing Cash Flow
14
38
68
118
0
53
11
Change in Cash
5
25
28
1
-21
12
-31

Global Institutional Holdings in Senti Biosciences

Check out the Institutions with significant holdings in Senti Biosciences.

Funds
Holdings
Lu Timothy K
1.89%
VANGUARD INDEX FUNDS
1.73%
Vanguard
1.73%
Fidelity Concord Street Trust
0.51%
Kanya Rajangam
0.18%
See all

Senti Biosciences News & Key Events

  • img

    Today's Timeline - 26 October

    Tue, 01:53 AM

    -

    Senti Biosciences completes merger, securing up to $60 million in milestone payments and acquiring key intellectual property for its programs.

Insights on Senti Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 16.0K → 17.0K (in $), with an average increase of 5.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 194.6% return, outperforming this stock by 288.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 861.9% return, outperforming this stock by 952.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SNTI stock has moved down by -17.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -4.22M → -12.75M (in $), with an average decrease of 202.1% per quarter

About Senti Biosciences

Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells. This allows the modified cells to interpret biological cues, make precise decisions, and react appropriately within their specific cellular surroundings. Their proprietary synthetic biology platform leverages readily available, "off-the-shelf" chimeric antigen receptor natural killer (CAR-NK) cells. This innovative approach is specifically designed to tackle formidable liquid and solid tumor cancers. Among their leading therapeutic candidates is SENTI-202. This "Logic Gated OR+NOT" off-the-shelf CAR-NK cell therapy is engineered to selectively identify and destroy acute myeloid leukemia (AML) cells, critically leaving healthy bone marrow unharmed. Another key program, SENTI-301, is a multi-armed, ready-to-use CAR-NK cell therapy being developed for the treatment of hepatocellular carcinoma (HCC). Additionally, SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy, aims to precisely eliminate colorectal cancer (CRC) cells without damaging the body's healthy tissues. Established in 2016, Senti Biosciences maintains its headquarters in South San Francisco, California.
OrganisationSenti Biosciences
Headquarters2 Corporate Drive, South San Francisco, CA, 94080, US
IndustryBiotechnology
CEOTimothy K. Lu

Key Management of Senti Biosciences

Name

Title

Dr. James J. Collins Ph.D.

Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director

Mr. Jay Cross

Chief Financial Officer

Mr. Faraz Siddiqui

Senior Vice President of Technical Operations

Mr. Robert H. Cutler J.D.

Senior VP & Head of Legal Affairs

Mr. Thomas P. Chung

Vice President of Strategic Finance & Corporate Development

Dr. Timothy K. Lu M.D., Ph.D.

Co-Founder, CEO & Director

Dr. Kanya Rajangam M.D., Ph.D.

President, Head of Research & Development and Chief Medical Officer

FAQs

What is Senti Biosciences share price today?

Senti Biosciences share price today is $0.18 as on at the close of the market. Senti Biosciences share today touched a day high of $0.19 and a low of $0.17.

What is the 52 week high and 52 week low for Senti Biosciences share?

Senti Biosciences share touched a 52 week high of $2.88 on and a 52 week low of $0.15 on . Senti Biosciences stock price today i.e. is closed at $0.18,which is 93.82% down from its 52 week high and 17.43% up from its 52 week low.

What is Senti Biosciences's market capitalisation today?

Senti Biosciences market capitalisation is $0.00T as on .

How to invest in Senti Biosciences Stock (SNTI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Senti Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Senti Biosciences Stock (SNTI) from India?

Indian investors can start investing in Senti Biosciences (SNTI) shares with as little as ₹94.73999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹947.40 in Senti Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Senti Biosciences share’s latest price of $0.18 as on November 4, 2026 at 8:46 am IST, you will get 56.2114 shares of Senti Biosciences. Learn more about fractional shares .